Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)

NCT01854658 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1615

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: GFF MDI (PT003)
DRUG: GP MDI (PT001)
DRUG: FF MDI (PT005)
DRUG: Placebo

Sponsor

Pearl Therapeutics, Inc.